NewsRx

Search our medical news database

Prostate Cancer

'Free PSA' Blood Test To Aid In Battle Against Cancer

Published in Cancer Weekly, March 23rd, 1998

The U.S. Food and Drug Administration (FDA) has approved a blood test to enhance the accuracy of prostate cancer detection.

The Hybritech Free PSA test is expected to significantly reduce the number of unnecessary prostate biopsies, lower healthcare costs and ease the anxiety of many men over age 50 who are at risk for prostate cancer.

The Hybritech Free PSA test developed by Beckman Coulter detects 95 percent of prostate cancers and is used by physicians to differentiate between prostate cancer and benign prostate conditions, said clinical researchers involved in a recent multi-center study.

Nearly all prostate cancers that are...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook